Enhanced Antibacterial Activity of Dermaseptin through Its Immobilization on Alginate Nanoparticles-Effects of Menthol and Lactic Acid on Its Potentialization

Dermaseptin B2 (DRS-B2) is an antimicrobial peptide secreted by <i>Phyllomedusa bicolor</i>, which is an Amazonian tree frog. Here, we show that the adsorption of DRS-B2 on alginate nanoparticles (Alg NPs) results in a formulation (Alg NPs + DRS-B2) with a remarkable antibacterial activi...

Full description

Saved in:
Bibliographic Details
Main Authors: Noura Hazime (Author), Yanath Belguesmia (Author), Alexandre Barras (Author), Mohamed Amiche (Author), Rabah Boukherroub (Author), Djamel Drider (Author)
Format: Book
Published: MDPI AG, 2022-06-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_c23a315e3adf40a6ab0ddd60976c17d6
042 |a dc 
100 1 0 |a Noura Hazime  |e author 
700 1 0 |a Yanath Belguesmia  |e author 
700 1 0 |a Alexandre Barras  |e author 
700 1 0 |a Mohamed Amiche  |e author 
700 1 0 |a Rabah Boukherroub  |e author 
700 1 0 |a Djamel Drider  |e author 
245 0 0 |a Enhanced Antibacterial Activity of Dermaseptin through Its Immobilization on Alginate Nanoparticles-Effects of Menthol and Lactic Acid on Its Potentialization 
260 |b MDPI AG,   |c 2022-06-01T00:00:00Z. 
500 |a 10.3390/antibiotics11060787 
500 |a 2079-6382 
520 |a Dermaseptin B2 (DRS-B2) is an antimicrobial peptide secreted by <i>Phyllomedusa bicolor</i>, which is an Amazonian tree frog. Here, we show that the adsorption of DRS-B2 on alginate nanoparticles (Alg NPs) results in a formulation (Alg NPs + DRS-B2) with a remarkable antibacterial activity against <i>Escherichia coli</i> ATCC 8739 and <i>E. coli</i> 184 strains, which are sensitive and resistant, respectively, to colistin. The antibacterial activity, obtained with this new formulation, is higher than that obtained with DRS-B2 alone. Of note, the addition of lactic acid or menthol to this new formulation augments its antibacterial activity against the aforementioned Gram-negative bacilli. The safety of DRS-B2, and also that of the new formulation supplemented or not with a small molecule such as lactic acid or menthol has been proven on the human erythrocytes and the eukaryotic cell line types HT29 (human) and IPEC-1 (animal). Similarly, their stability was determined under the conditions mimicking the gastrointestinal tract with different conditions: pH, temperature, and the presence of digestive enzymes. Based on all the obtained data, we assume that these new formulations are promising and could be suggested, after <i>in vivo</i> approval and completing regulation aspects, as alternatives to antibiotics to fight infections caused by Gram-negative bacilli such as <i>E. coli</i>. 
546 |a EN 
690 |a dermaseptin 
690 |a DRS-B2 
690 |a alginate nanoparticles 
690 |a menthol 
690 |a lactic acid 
690 |a synergy 
690 |a Therapeutics. Pharmacology 
690 |a RM1-950 
655 7 |a article  |2 local 
786 0 |n Antibiotics, Vol 11, Iss 6, p 787 (2022) 
787 0 |n https://www.mdpi.com/2079-6382/11/6/787 
787 0 |n https://doaj.org/toc/2079-6382 
856 4 1 |u https://doaj.org/article/c23a315e3adf40a6ab0ddd60976c17d6  |z Connect to this object online.